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Abstract
Claudication is the most common symptomatic manifestation of peripheral arterial disease (PAD), producing signiﬁcant ambulatory
compromise. The purpose of this study was to use advanced biomechanical gait analysis to determine the gait alterations occurring in
claudicating patients both before and after onset of claudication pain in their legs. Hip, knee, and ankle joint moments were measured in
claudicating patients (age: 64.4678.47 years; body mass: 80.70712.64 kg; body height: 1.7270.08 m) and were compared to
gender–age–body mass–height-matched healthy controls (age 66.2779.22 years; body mass: 77.89710.65 kg; body height:
1.7470.08 m). The claudicating patients were evaluated both before (pain-free (PF) condition) and after (pain condition) onset of
claudication pain in their legs. Thirteen symptomatic PAD patients (26 claudicating limbs) with bilateral intermittent claudication (IC)
and 11 healthy controls (22 control limbs) were tested during level walking at their self-selected speed. Compared to controls, PAD hip
and ankle joints demonstrated signiﬁcant angular kinematics and net internal moment changes. Alterations were present both in PF and
pain conditions with several of them becoming worse in the pain condition. Both PF and pain conditions resulted in signiﬁcantly reduced
peak hip extensor moment (5.6271.40 and 5.6371.33% BW  BH, respectively) during early stance as compared to controls
(7.5371.16% BW  BH). In the pain condition, PAD patients had a signiﬁcantly reduced ankle plantar ﬂexor moment (7.5671.41%
BW  BH) during late stance as compared to controls (8.6571.27% BW  BH). Furthermore, when comparing PF to pain conditions,
there was a decreased peak plantar ﬂexor moment (PF condition: 8.2371.37 vs. pain condition: 7.5671.41% BW  BH) during late
stance. The ﬁndings point to a weakness in the posterior compartment muscles of the hip and calf as being the key factor underlying the
PAD gait adaptations.
Our ﬁndings establish a detailed baseline description of the changes present in PAD patient’s joint angles and moments during
walking. Since IC is primarily a gait disability, better understanding of the abnormalities in joint and muscle function will enhance our
understanding of the gait impairment and may lead to novel, gait-speciﬁc treatments.
r 2008 Elsevier Ltd. All rights reserved.
Keywords: Peripheral arterial disease; Claudication; Joint moment; Biomechanics; Gait

1. Introduction
Intermittent claudication (IC) is the most common
symptomatic manifestation of peripheral arterial disease
(PAD) presenting as ischemic leg muscle pain and gait
Corresponding author. Tel.: +1 402 554 3246; fax: +1 402 554 3693.

E-mail address: shingjychen@mail.unomaha.edu (S.-J. Chen).
0021-9290/$ - see front matter r 2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.jbiomech.2008.05.011

dysfunction. Claudication pain is the result of exerciseinduced reduction in blood supply to the working muscle
of the lower extremity (Meru et al., 2006). This ischemic
pain is induced by physical activity (i.e. walking) and
relieved during rest. IC and its associated ambulatory
dysfunction are associated with poor health outcomes,
physical dependence (Atkins and Gardner, 2004; Gardner
and Clancy, 2006) and impaired quality of life (Liles et al.,
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2006; Menard et al., 2004). Currently, baseline ambulatory
impairment and success of treatment (e.g., supervised
treadmill based exercise, angioplasty, bypass) are evaluated
using limited clinical (resting Ankle–Brachial Index (ABI),
walking distance evaluation) (Oka et al., 2005) and
rudimentary time–distance tools (Gardner et al., 2001;
McDermott et al., 2001). Previous work has demonstrated that PAD patients walk slower with a decreased
cadence, increased stance time, shorter stride length
and a narrower step width as compared with controls
(Gardner et al., 2001; McDermott et al., 2001).
However, these changes are unable to describe in detail
the speciﬁc physical impairments of claudicating
patients and in our understanding of its underlying
pathophysiology.
Detailed quantitative evaluation of gait can be provided
using advanced biomechanical analysis with joint kinetics
and kinematics (Fosang and Baker, 2006; Winter, 2005).
This analysis has been used extensively to characterize gait
abnormalities of patients with cerebral palsy (Chang et al.,
2006), stroke (McGinley et al., 2006; Yavuzer et al., 2006),
head injury (Basford et al., 2003; Vallée et al., 2006) and
other neuromuscular disorders (Barker et al., 2006; Runge
and Hunter, 2006). Furthermore, advanced biomechanical
analysis has been used to guide rehabilitation and surgical
treatment (Baker, 2006; Jöbges et al., 2004) and assess
therapeutic outcomes (Georgoulis et al., 2007; Stergiou
et al., 2007). Therefore, the purpose of the present study
was to utilize advanced biomechanical analysis in order to
determine the gait impairment of claudicating PAD
patients. Joint kinetic and kinematic parameters were
evaluated in PAD patients before and after the onset of
claudication pain while walking in pain-free (PF) and pain
(P) conditions, respectively. The PAD patients were
compared to gender-, height-, mass-, and age-matched
healthy controls. We also explored the relationships
between ABI, the Walking Impairment Questionnaire
(WIQ) subscale scores, and peak joint moments while
walking. We hypothesized that as patients experienced pain
due to lack of blood ﬂow in the claudicating limbs, the gait
parameters would be signiﬁcantly altered as compared to
baseline ambulation and healthy controls. We also
hypothesized that the resting ABI and WIQ scores would
positively correlate with the peak joint moments.
2. Methods
2.1. Subject inclusion and exclusion criteria
Thirteen male and female symptomatic PAD patients (age: 64.4678.47
years, body mass: 80.70712.64 kg; body height: 1.7270.08 m) diagnosed
with moderate arterial occlusive disease and bilateral claudication were
recruited from the vascular surgery clinics of the local Medical Centers. In
addition, 11 gender-, age-, body mass-, and height-matched healthy
controls (age: 66.2779.22 years, body mass: 77.89710.65 kg; body
height: 1.7470.08 m) volunteered to participate. Patients and controls
were screened and evaluated by two board certiﬁed vascular surgeons.
Those PAD patients with ambulation limiting cardiac, pulmonary,
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neuromuscular, or musculoskeletal disease or those who experienced
pain or discomfort during walking for any reason other than claudication
(i.e. arthritis, low back pain, musculoskeletal problems, neuropathy) were
excluded. Patient evaluation included resting ABI (a measurement below
0.90 was present in all subjects with claudication), detailed history,
physical exam, and direct assessment/observation of the patient’s walking
impairment. A vascular surgeon observed the patient walking and
recorded all symptoms and signs affecting ambulation to ensure limitation
was secondary to claudication pain.
Control subjects had an ABI greater than 0.90 and no subjective or
objective ambulatory dysfunction. Controls were screened in a similar
fashion as PAD patients and were excluded for the same ambulation
limiting problems or if pain was experienced during walking. Informed
consent was obtained from all subjects prior to data collection according
to the guidelines of the University’s Institutional Review Board. The gait
of all recruited participants was tested in the Biomechanics Laboratory.
In addition to gait analysis, the self-administered modiﬁed WIQ (Coyne
et al., 2003) including the four subscales of (a) pain severity, (b) walking
distance, (c) speed, and (d) stair climbing was obtained from all recruited
patients.

2.2. Experimental procedure and data collection
Prior to data collection, reﬂective markers were placed at speciﬁc
anatomical locations of each subject’s lower limb utilizing the modiﬁed
Helen Hayes marker set (Houck et al., 2004). Each subject was directed to
walk using their self-selected pace over a 10 m pathway, while threedimensional (3D) marker trajectories and ground reaction force data were
simultaneously collected. The 3D marker trajectories were captured with a
six high-speed real-time camera system (EvaRT 5.0, Motion Analysis
Corporation, Santa Rosa, CA) sampling at 60 Hz. The ground reaction
force data were acquired with a Kistler force platform sampling at 600 Hz.
Each patient was tested in the ‘‘PF’’ condition and then in the pain (P)induced condition. During PF testing, mandatory rest occurred between
walking trials to ensure that all trials were in a PF condition. Once patients
completed all PF trials, P trials were performed. In order to accomplish
this, a common clinical protocol was used where each patient was asked to
walk on an inclined treadmill with 10% grade at a speed of 1.5 mph
(DiBianco et al., 1984) until claudication pain was established. The
patients were then immediately removed from the treadmill and returned
to the collection walk-way to acquire the data for the P condition without
the mandatory resting periods. Controls completed only the PF condition
trials. A total of ﬁve successful walking trials was collected from each leg
of the subjects for each condition. A successful walking trial was
determined by the subject’s foot being completely within the force
platform.

2.3. Data analysis
Peak values of the joint kinetics and kinematics measured in the sagittal
plane during the early and late stance phases were analyzed (Figs. 1 and 2).
Time–distance parameters were also analyzed from one complete stride of
each subject and for each testing condition. A low-pass fourth-order
Butterworth ﬁlter with a 6 Hz cutoff was used to smooth the marker
trajectories during post-data processing. The OrthoTrak 6.29 software
package (Motion Analysis Corporation, Santa Rosa, CA) was used to
calculate the time–distance parameters, the joint kinetics, and kinematics
of each subject. The joint kinetics was scaled to body weight and body
height.

2.4. Statistical analysis
Group means of the peak joint kinetics, peak joint kinematics, and the
time–distance parameters were calculated for each testing condition (PF
and P conditions) by combining all legs of each group. Thus, an N of 26
limbs was generated for the PAD group and an N of 22 limbs for the
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Fig. 1. The ensemble-average ﬂexion and extension of both supporting limbs for the PAD patients (Pt: pain free and pain; N ¼ 26 limbs) and the controls
(Ctrl: N ¼ 22 limbs) during the stance phase for the (a) hip, (b) knee, and (c) ankle joints. Note: HFp1/HEp2: hip ﬂexion/extension peak 1 and peak 2
during the early and late stance phases, respectively. KFp1/KEp2: knee ﬂexion/extension peak 1 and peak 2 during the early and late stance phases,
respectively. APFp1/ADFp2: ankle plantar ﬂexion/dorsiﬂexion peak 1 and peak 2 during the early and late stance phases, respectively. *po0.05,
signiﬁcant differences between testing conditions (PF vs. P). **po0.05, signiﬁcant differences between groups (patient PF condition vs. control PF).
***po0.05, signiﬁcant differences between groups (patient P condition vs. control PF).
control group. Paired t-tests were used to detect the effects of induced
claudication pain, and independent t-tests were used to examine group
effects for each dependent variable. Pearson correlations were performed
to evaluate the relationships between the patients’ ABIs, the peak joint

moments, and the WIQ four subscales in the PF and P conditions. The
level of signiﬁcance was set at 0.05. Parametric statistics were utilized
because gait analysis data have been shown to demonstrate normality
(Benedetti et al., 1998).
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Fig. 2. The ensemble-average net extensor/ﬂexor moment curves of both supporting limbs for the patients (Pt: pain free and pain; N ¼ 26 limbs) and the controls
(Ctrl: N ¼ 22 limbs) during the stance phase for the (a) hip, (b) knee, and (c) ankle joints. A positive (+) value indicates a net internal extensor/plantar ﬂexor
moment, and a negative () value indicates a net internal ﬂexor/dorsiﬂexor moment. Moments are normalized to body weight (BW) and body height (BH). Note:
HEM p1/HFM p2: hip extension/ﬂexion moment peak 1 and peak 2 during the early and late stance phases, respectively. KEM p1/KFM p2: knee extension/
ﬂexion moment peak 1 and peak 2 during the early and late stance phases, respectively. ADFM p1/APFM p2: ankle dorsiﬂexion/plantar ﬂexion moment peak 1
and peak 2 during the early and late stance phases, respectively. *po0.05, signiﬁcant differences between testing conditions (PF vs. P). **po0.05, signiﬁcant
differences between groups (patient PF condition vs. control PF). ***po0.05, signiﬁcant differences between groups (patient P condition vs. control PF).
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were found for step width. Comparing the PF to P
conditions, there was a signiﬁcant decrease in the gait
velocity and stride length (Table 2).

3. Results
3.1. Time–distance gait measurements
The baseline clinical characteristics of the patients
(N ¼ 26 limbs) and the healthy controls (N ¼ 22 limbs)
are presented in Table 1. When compared to controls,
patients showed signiﬁcant decreases in gait velocity, stride
length, and cadence and a signiﬁcant increase in double
support time in the PF condition (Table 2). The differences
for the same parameters were further ampliﬁed when the P
condition was compared with the controls. Additional
signiﬁcant differences were also present with increased
stance phase, increased double support phase, and
decreased swing phase (Table 2). No signiﬁcant differences
Table 1
Baseline characteristics of bilateral claudicating PAD patients and healthy
control subjects
Clinical characteristics

Patient (26 limbs)

Control (22 limbs)

Gender (male/female)
Age (years)
Body mass (kg)
Body height (m)
Disease duration (years)

12/1
64.4678.47
80.70712.64
1.7270.08
6.2573.84

10/1
66.2779.22
77.89710.65
1.7470.08
0

ABI
Right limb
Left limb
Smokers, n (%)
Hypertension, n (%)
Diabetes mellitus, n (%)
Hyperlipidemia, n (%)
BMI

0.4970.16
0.5670.17
0 (0)
11 (84.6)
0 (0)
12 (92.3)
27.1674.51

1.170.11
1.170.09
0 (0)
0 (0)
0 (0)
0 (0)
25.6072.94

WIQ domains
Claudication pain
Walking distance
Walking speed
Stair climbing

57.69715.76
47.37723.29
47.44728.31
52.57725.77

n/a
n/a
n/a
n/a

3.2. Joint angles
Several changes were noted both in the early stance (after
heel contact or braking phase) and the late stance (before
toe off or propulsion phase). In comparison with controls,
patients in the PF condition showed a signiﬁcantly
decreased hip peak ﬂexion (34.75177.1 vs. 30.95175.20,
respectively) during the early stance, a signiﬁcantly
increased peak ankle plantar ﬂexion (2.43172.11 vs.
3.63171.86, respectively) during the early stance, and a
signiﬁcantly
increased
peak
ankle
dorsiﬂexion
(15.09173.01 vs. 17.14172.89, respectively) during late
stance. Once in the P condition, the results for the same
parameters remained signiﬁcantly different compared to
healthy controls (Fig. 1). Furthermore when comparing PF
to P conditions, there was signiﬁcantly increased peak hip
ﬂexion (PF: 30.95175.20 vs. P: 32.41175.32) at the early
stance and signiﬁcantly decreased peak hip extension at
late stance for the patients (Fig. 1). In addition, the P
condition resulted in a signiﬁcantly increased peak ankle
dorsiﬂexion during the late stance.
3.3. Joint moments

Note: ABI: Ankle–Brachial Index; BMI: Body Mass Index; WIQ: Walking
Impairment Questionnaires; n: a number of subjects.

Patients in the PF condition had a signiﬁcantly reduced
peak hip extensor moment (5.6271.40% BW  BH) during
early stance as compared to controls (7.5371.16%
BW  BH) (Fig. 2a). In the P condition, patients were found
to have a signiﬁcantly reduced peak hip extensor moment
(5.6371.33% BW  BH) during early stance and a signiﬁcantly reduced ankle plantar ﬂexor moment
(7.5671.41% BW  BH) during late stance as compared to
controls (7.5371.16 and 8.6571.27, respectively; Fig. 2a and
c). Furthermore, when comparing PF to P, there was a
decreased peak plantar ﬂexor moment (PF: 8.2371.37 vs. P:
7.5671.41) during the late stance (Fig. 2c).

Table 2
Time–distance gait measurements for both patient and control groups
Patient (N ¼ 26 limbs)

Gait velocity (m/s)
Stride length (m)
Cadence (steps/min)
Step width (m)
Stance phase (%)
Swing phase (%)
Double support (%)

Control (N ¼ 22 limbs)

Pain free (PF)

Pain (P)

Pain free (PF)

1.1470.14,
1.3470.11,
102.1978.49
0.1470.04
61.4572.57
38.6272.59
11.8771.95

1.0770.11
1.2870.10
100.7177.36
0.1570.03
61.7272.61
38.3172.61
12.3872.52

1.3770.15
1.5270.10
108.3479.05
1.3270.03
59.7573.04
40.2573.04
10.2171.97

 po0.05, signiﬁcant differences between testing conditions (PF vs. P).
 po0.05, signiﬁcant differences between groups (patient PF condition vs. control PF).
 po0.05, signiﬁcant differences between groups (patient P condition vs. control PF).
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Table 3
Pearson correlations (r) among the peak joint moments at hip, knee, and ankle during walking without pain (PF) and with pain (P) claudication
conditions, resting ABI, and the four WIQ subscales for pain, walking distance, speed, and stairs
Pain condition
Pain free (PF)
ABI
WIQ: pain
WIQ: distance
WIQ: speed
WIQ: stairs

ABI WIQ pain WIQ distance WIQ speed WIQ stairs ADFM p1 APFM p2 KEM p1 KFM p2 HEM p1 HFM p2

0.476

0.67
0.59

0.45
0.57
0.62

0.21
0.24
0.35
0.71

Pain (P)
ABI
WIQ: pain
WIQ: distance
WIQ: speed
WIQ: stairs

0.44
0.13
0.20
0.06
0.35

.17
0.075
0.325
0.65
0.56

0.25
0.71
0.51
0.70
0.54

0.09
0.66
0.20
0.06
0.02

0.19
0.00
0.11
0.43
0.23

0.05
0.32
0.01
0.04
0.08

0.32
0.14
0.24
0.09
0.36

0.18
0.10
0.15
0.53
0.53

0.27
0.68
0.41
0.71
0.60

0.10
0.09
0.13
0.68
0.71

0.19
0.03
0.07
0.42
0.29

0.13
0.27
0.04
0.15
0.03

ADFM p1: ankle dorsiﬂexion/plantar ﬂexion moment peak 1 during early stance phase.
APFM p2: ankle dorsiﬂexion/plantar ﬂexion moment peak 2 during late stance phase.
KEM p1: knee extension/ﬂexion moment peak 1 during early stance phase.
KFM p2: knee extension/ﬂexion moment peak 2 during late stance phase.
HEM p1: hip extension/ﬂexion moment peak 1 during early stance phase.
HFM p2: hip extension/ﬂexion moment peak 2 during late stance phase.
 Correlation is signiﬁcant at the 0.05 level (2-tailed).

3.4. Correlations
The ABI was found to have a moderate positive
correlation with the WIQ subcategory of distance
(r ¼ 0.67; Table 3). During the PF condition, the peak
ankle plantar ﬂexor moment had moderate negative
correlations with the WIQ subcategories of speed
(r ¼ 0.65) and stairs (r ¼ 0.56). However, these correlations became non-signiﬁcant in the P condition. Moderate
positive correlations were found between the knee extensor
moment and the WIQ subcategories of pain (r ¼ 0.71) and
speed (r ¼ 0.70) in the PF condition. In the P condition,
an additional moderate positive correlation was found
between the WIQ subcategory stairs and the peak knee
extension moment (r ¼ 0.60). Knee ﬂexion moment was
found to have a signiﬁcant and moderate positive correlation with the WIQ subcategory of pain (r ¼ 0.66) during
the PF condition, and the WIQ subcategory of speed
(r ¼ 0.68) as well as the WIQ subcategory of stairs
(r ¼ 0.71) during the P condition.
4. Discussion
The purpose of this study was to utilize advanced
biomechanical analysis to determine the gait impairment of
claudicating PAD patients. The present study is the ﬁrst to
provide a detailed quantitative evaluation of the joint
kinematic and kinetic changes in PAD patients with
bilateral intermittent claudication. Other studies have
utilized either just joint kinematics from two-dimensional
gait analysis (Crowther et al., 2007) or just ground reaction
forces for a kinetic evaluation (Scott-Pandorf et al., 2007),
thus providing a limited functional evaluation in gait. Joint

kinetics and kinematics were examined while PAD patients
walked both with and without claudication pains and were
compared to those of gender-, age-, body mass-, and
height-matched controls. Our data demonstrate that the
gait of claudicating patients is signiﬁcantly affected
both before and after they experience claudication symptoms in their legs. Taken literally, the gait of PAD patients
is abnormal from the ﬁrst step they take. The character of
the PAD gait based on our time–distance data appears
overall ‘‘sluggish and tired’’ with the majority of the
changes becoming most apparent at the level of the hip
and ankle joints. The most important ﬁndings of this
work, however, lie with our joint angle and joint moment
data. These data in combination with our time–distance
ﬁndings suggest that the underlying mechanism in the
abnormal PAD gait is a weakness of the hip extensors
(gluteal and posterior thigh muscles) and ankle plantar
ﬂexors (posterior calf compartment muscles). This weakness appears to be the operating mechanism behind the
observed decreased hip extensor and ankle plantar ﬂexor
moments. These are then translated at the hip level to
decreased hip joint ﬂexion and at the ankle level to
increased ankle plantar ﬂexion after heel contact (braking
period) and increased ankle dorsiﬂexion during push off,
ﬁnally producing the ‘‘sluggish and tired’’ appearing gait of
claudicating patients. Gait adaptations, but not ABI,
correlated well with all four WIQ subscales indicating
that gait impairment quantiﬁcation via advanced biomechanical analysis may be the most clinically relevant
corollary of quality of life deterioration in claudicating
patients. ABI did not correlate well with the advanced
biomechanical parameters, suggesting that as a hemodynamic index ABI is unable to capture the complexity of the
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PAD effects on the locomotor pathophysiology of the
claudicating limb.
Regarding time–distance parameters, our data demonstrate that compared with healthy controls, PAD patients
walk slower, with decreased cadence and decreased stride
length, thus spending more time in double support. This all
occurs while the PAD patient is walking PF and worsens
when the patient experiences claudication leg pain at which
time the PAD patient also experiences an increase in stance
time and a decrease of the swing phase. Our results are in
agreement with those of other studies in PAD patients
(Gardner et al., 2001; McDermott et al., 2001) and conﬁrm
there is a deﬁnite and signiﬁcant alteration in gait function
in patients with PAD at baseline.
Regarding joint kinematics and kinetics, our data
demonstrate that compared to healthy controls, PAD
patients had reduced peak hip ﬂexion and an increased
peak ankle plantar ﬂexion during braking followed by an
increased peak ankle dorsiﬂexion during propulsion.
Similarly, compared to healthy controls, PAD patients
had reduced peak hip extensor and peak ankle plantar
ﬂexor moment. These joint angle and moment changes
were present while walking without pain and remained
signiﬁcantly different or even worse with induced pain.
The reduced peak hip extensor moment is probably the
result of weakness and pain in the extensor muscle group
(gluteal and posterior hip compartment muscles). Furthermore, decreased ankle plantar ﬂexor moment suggests
weakness of the posterior calf compartment muscles that
are unable to adequately propel the claudicating limb.
Taken together, these muscle group abnormalities can
explain the need claudicants have for shorter steps and
spending more time in double support, which in turn
results in decreased hip ﬂexion during the braking phase
and hip extension during the propulsion phase of walking.
The increased ankle dorsiﬂexion prior to toe off maybe the
result of plantar ﬂexor weakness or a mechanism that
allows further stretching of the posterior calf compartment
muscles in an attempt to assist them in propulsion.
Similarly, the initial increased ankle plantar ﬂexion may
reﬂect weakness of the anterior calf compartment muscles
that are unable to hold the foot ﬂexed after heel touch
down.
Our ﬁnding of reduced hip extensor moment is similar to
results from elderly populations (Kerrigan et al., 1998;
Riley et al., 2001). This result may also explain the
contradiction that is found in the literature regarding the
hip moment in the elderly, where two studies conducted by
Kerrigan et al. (1998) and Riley et al. (2001) have shown
deﬁciencies at the hip for the elderly, while Judge et al.
(1996) reported no signiﬁcant differences at the hip.
Because PAD screening has not been performed in these
studies, it is possible that the results have been confounded
by PAD being present in different subsets of the patients
enrolled in these studies. It has been shown that 20–30% of
the elderly population above the age of 65 have PAD in
different stages (McDermott, 2002). Therefore, it becomes

obvious that appropriate patient screening with exclusion
of PAD patients ought to be a necessary step in the design
of future gait evaluation studies in the elderly. Decreased
plantar ﬂexor moment is a ﬁnding observed not only in the
elderly (Kerrigan et al., 1998; Riley et al., 2001) but also in
disabled patients suffering mostly from osteoarthritis
(Kaufman et al., 2001; McGibbon et al., 2001). Reduced
plantar ﬂexor function could affect swing initiation
(a signiﬁcant decrease in swing phase has been observed
in this study) and trunk progression late in stance (Neptune
et al., 2001). Overall, the altered hip and ankle joint
kinematics and kinetics we have identiﬁed suggest that the
propulsion muscles of the leg are weak and fail to support
the body in forward progression. This hypothesis is
supported by previous ﬁndings in our and other laboratories demonstrating PAD patients have signiﬁcantly
decreased propulsion forces (Scott-Pandorf et al., 2007)
and ankle plantar ﬂexor strength (Scott-Okafor et al.,
2001).
As current guidelines recommend the use of qualitative
self-reported measures during studies performed for
claudication (Norgren et al., 2007), we evaluated the
correlation of advanced biomechanical parameters, ABI
and the WIQ subscales. The resting ABI is commonly used
as a measure of the hemodynamic compromise seen with
PAD (Bauman and Arthur, 1997; Gardner et al., 1997),
with a lower ABI value thought to indicate worse
claudication effects. ABI did not correlate well with any
of the advanced biomechanical parameters, but correlated
only with the WIQ subcategory of claudication distance.
This ﬁnding is in agreement with the results from
Izquierdo-Porrera et al. (2005). The above ﬁndings continue to underscore that ABI cannot adequately capture
the complexity of the PAD (Green, 2002; McKenna et al.,
1991). The small numbers of the signiﬁcant correlations
(5 out of 24 correlations) found between the WIQ
subcategories and the joint kinetics may be attributed to
the subjective nature of the WIQ evaluation. The small
insigniﬁcant correlations between the ABI and the joint
kinetics suggest that the clinical ABI measurement may be
limited to provide a direct functional evaluation of PAD
patients’ walking.
Our work points to a weakness in the posterior
compartment muscles of the hip and calf as being the key
factor underlying the multitude of alterations that characterize PAD gait. Interestingly, this weakness is present
before and appears to worsen after the onset of claudication. This ﬁnding is consistent with previous reports that
demonstrate a muscle metabolic myopathy (Brass and
Hiatt, 2000) and an axonal polyneuropathy in the lower
extremities of PAD patients (Weber and Ziegler, 2002).
Speciﬁcally, a number of reports have documented a
metabolic myopathy in the PAD muscle that appears to
be secondary to defective mitochondrial bioenergetics and
related oxidative damage to skeletal muscle structures and
components (Pipinos et al., 2006). Mitochondria in PAD
muscle have abnormal ultrastructure (Marbini et al., 1986),
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damaged DNA (Bhat et al., 1999), altered enzyme
expression and activity, and abnormally high intermediates
of oxidative metabolism (Lundgren et al., 1988).
Most importantly, evaluations of claudicating muscle
mitochondrial bioenergetics demonstrate speciﬁc defects
in the complexes of electron transport chain with
associated compromised mitochondrial respiration
(oxidative phosphorylation) and ATP production
(Kemp, 2004; Pipinos et al., 2006). This is very similar to
those seen in mitochondrial myopathies (Kemp, 2004;
Pipinos et al., 2006). Recent work also demonstrates that
the mitochondriopathy of PAD muscle is associated with
evidence of signiﬁcant oxidative damage to the muscle
components (Pipinos et al., 2006). Furthermore,
there is accumulating evidence suggesting that chronic
ischemia in PAD patients results in a consistent pattern of
electrodiagnostic abnormalities indicating axonal nerve
loss (Koopman et al., 1996; Weber and Ziegler, 2002).
Therefore, the impairments we have identiﬁed at baseline
may be reﬂecting a combination of myopathy and
neuropathy in the PAD limbs that becomes worse
when exercise-induced ischemia produces progressively
worsening ischemic muscle pain and restriction of the
lower extremity bioenergetics. The nature of these myopathic and neuropathic changes and the way they are
related to the clinical biomechanical ﬁndings of leg
dysfunction should be the focus of intense future investigation and may hold the key to understanding PAD
pathophysiology.
In summary, biomechanical gait analysis indicates
signiﬁcant abnormalities in the gait of claudicating
patients. These abnormalities are present both before and
after the onset of claudication with several of them
becoming worse after claudication onset. Our work points
to a weakness in the posterior compartment muscles of the
hip and calf as being the key factor underlying the
multitude of adaptations that characterize PAD gait. These
ﬁndings introduce new insights into the pathophysiology of
claudicating gait and suggest that biomechanical evaluation may provide a ﬁrm foundation for optimal clinical
decision-making and assist in an objective measurement of
functional outcomes after medical and surgical therapy.
For example, vascular surgeons could use the altered gait
revealing a speciﬁc joint dysfunction of PAD patients to
further gain a close scrutinizing procedure about the level
of the occlusion prior to a vascular treatment. The altered
gait provides a better quantiﬁcation of the gait abnormality, which subsequently can be addressed surgically to
further evaluate gait improvement for the patients by
comparing the data before and after treatment. More
importantly, the clinicians could use the altered gait to
provide a speciﬁc joint rehabilitation for PAD patients
instead of giving a whole body exercise on treadmill. Thus,
biomechanical analysis may facilitate the identiﬁcation of
optimal rehabilitative regimens that could correct the
abnormal gait patterns, allowing for greater exercise
tolerance.
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